<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-050040</identifier>
<setSpec>1137-2273</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Scientific evidence of the hormonal substitute treatment at present</dc:title>
<dc:description xml:lang="en">Until recent times, in Spain the symptoms        that happened during the periodo f the menopause        (hot flashes, sweating, change in the character,        etc) they were considered like ailments        characteristics of the age and therefore without        treatment necessity, without keeping in mind        that the menopause on the contrary is the woman&#146;s        long stage that she specifies treatment in        many occasions. Repeatedly has been insisted        that the Hormone Replacement Therapy. It is        vastly effective in the Osteoporosis and in the        coronary heart disease. Spain is one of the        countries of the European Union with smaller        percentage of user of THS, approximately the        susceptible population&#146;s of treatment 5%, contrary        to the European stocking settled down in        20%. There is analyzed in this study the scientific        evidence published on THS&#146;s use</dc:description>
<dc:creator>Rodríguez Rodríguez, J. M</dc:creator>
<dc:creator>Martínez Payo, C</dc:creator>
<dc:creator>Tamarit Degenhardt, I</dc:creator>
<dc:creator>Luque Mialdea, A</dc:creator>
<dc:creator>Benavente Berzosa, A</dc:creator>
<dc:creator>Ros Berruzo, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Hasta épocas recientes, en España la sintomatología        que acontecía durante el periodo de        la menopausia (sofocos, sudores, cambios en el        carácter, etc) se consideraban como achaques        propios de la edad y por tanto sin necesidad de        tratamiento, sin tener en cuenta que la menopausia        por el contrario es una larga etapa de la        mujer que en muchas ocasiones precisa de tratamiento.        Se ha insistido reiteradamente que la        Terapia Hormonal Sustitutiva (THS) es enormemente        eficaz en la osteoporosis y en la cardiopatía        isquémica. España es uno de los países de        la Unión Europea con menor porcentaje de uso        de THS, aproximadamente un 5% de la población        susceptible de tratamiento, a diferencia de        la media Europea establecida en un 20%. Se        analiza en este estudio la evidencia científica        publicada sobre el uso de THS</dc:description>
<dc:source>Cienc. ginecol;10(6): 321-324, nov.-dic. 2006.</dc:source>
<dc:identifier>ibc-050040</dc:identifier>
<dc:title xml:lang="es">Evidencia científica del tratamiento hormonal sustitutivo en la actualidad</dc:title>
<dc:subject>^d33862^s22011</dc:subject>
<dc:subject>^d33862^s22066</dc:subject>
<dc:subject>^d33862^s22045</dc:subject>
<dc:subject>^d29623</dc:subject>
<dc:subject>^d33862^s22083</dc:subject>
<dc:subject>^d33862^s22074</dc:subject>
<dc:subject>^d13507^s22080</dc:subject>
<dc:subject>^d33862^s37748</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d10205^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d22129^s22031</dc:subject>
<dc:subject>^d6484^s22080</dc:subject>
<dc:subject>^d13507^s22054</dc:subject>
<dc:subject>^d1968^s22080</dc:subject>
<dc:subject>^d33150^s22045</dc:subject>
<dc:subject>^d12225</dc:subject>
<dc:subject>^d33150^s22066</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d33150^s22048</dc:subject>
<dc:type>article</dc:type>
<dc:date>200612</dc:date>
</metadata>
</record>
</ibecs-document>
